Skillable gets Top 50 spot in G2 2025 ‘Best Education Software' awards and becomes Virtual IT Labs Leader for 15th time
Skillable has been recognized by peer-to-peer review site G2 as a Virtual IT Labs Leader for the 15th consecutive time and a Top 50 Education Software product .
'The 2025 Best Software Award winners represent the very best in the industry, standing out for their exceptional performance and customer satisfaction.' — Godard Abel, Co-founder and CEO at G2
NEW PORT RICHEY, FL, UNITED STATES, April 9, 2025 / EINPresswire.com / -- Skillable, the pioneer in performance-based learning and skill validation, has been recognized as a Virtual IT Labs leader for the 15th consecutive time in the G2 Spring 2025 report, which is based on verified reviews from business leaders, Instructors and learners using the Skillable lab platform. Alongside its category leadership, Skillable gained 50 badges, including leader badges in Implementation Index, Results, User Satisfaction, Meets Requirements and Value.
In addition to the badges earned for user reviews, G2 selected Skillable as a Top 50 Education Software product in their 2025 Best Software Awards list. G2's Best Software Awards feature dozens of lists, ranking software vendors and products using G2's proprietary algorithm based on G2's verified user reviews and publicly available market presence data.
'The stakes for choosing the right business software are higher than ever,' said Godard Abel, Co-founder and CEO at G2. 'With over 180,000 software products and services listings and 2.9 million verified user reviews in the G2 marketplace, we're proud to help companies navigate these critical choices with insights rooted in authentic customer feedback. The 2025 Best Software Award winners represent the very best in the industry, standing out for their exceptional performance and customer satisfaction. Congratulations to this year's honorees!'
Users consistently mention the effectiveness of Skillable's hands-on training to complement theoretical knowledge sharing through courses, classrooms and Instructor-led training, with immersive experiences in the technologies and processes that learners will use in their daily lives. This facilitates greater skill mastery, knowledge retention and real-world application.
As one G2 user explains, 'Adults learn better if they can follow a book, hear the Instructor and practice hands-on training. The success rate is far better for individuals who can do all three of the above learning methods. Skillable provides that type of atmosphere.'
Skillable's continuous leadership of the Virtual IT Labs category is underpinned by its ongoing innovation to bring hands-on experiences to more learners across customer, partner, technical sales and employee cohorts, its market expansion into new geographies including Europe and India and its strategic partnerships with leading learning, HR and Global System Integrators including Cornerstone, Docebo, Degreed and Multiverse.
With 99.99% average uptime in the platform and the ability to scale to tens of thousands of concurrent users, the reliability and connectivity of Skillable is also regularly mentioned by G2 reviewers. As one Microsoft Certified Trainer and G2 reviewer recently said, 'The platform is reliable and in the past four years, there's never been an issue with connectivity...'
Sarah Danzl, Chief Marketing Officer at Skillable, comments, 'Hands-on experiences are proving to be the most impactful and effective way for learners to get the skills they need to use software and stay ahead of technological change. As our G2 reviewers continuously state, Skillable is an integral part of their student instruction, revenue and partner enablement, customer training and employee upskilling. This is something that drives us to push the boundaries with the platform, to help every learner build robust technical skills that are ready for the real world and validate those skills to unlock future opportunities. And so, we are honored to be named a leader in Virtual IT Labs by our G2 reviewers, along with earning a Top 50 spot in G2's Best Education Software list.'
See the Skillable platform in action here.
+1 347-966-6544
X
LinkedIn
Legal Disclaimer:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
AI's agentic era will augment worker capacities: Cisco president
Meta Platforms (META) is planning to invest $14 billion into artificial intelligence infrastructure developer Scale AI in a new deal reported by CNBC, the latest headline in the AI Revolution as more firms adopt AI agents onto their platforms. Cisco Systems (CSCO) President and Chief Product Officer Jeetu Patel comes on Catalysts to speak with Madison Mills on the company's investments and acquisition of AI firms, the adoption of AI applications in the workforce, and expansion plans. Catch RBC Capital Markets managing director Rishi Jaluria share his perspective on the software environment and AI adoption amid the Trump administration's economic policies. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. Meta could pay nearly $15 billion for stake in scale AI, according to a report from the Information, as the company looks to expand its AI ambitions. Joining me now on this and more G2 Patel. He is Cisco's President and Chief Product Officer. Great to have you on this morning, G2. The latest AI investment from a tech company with regards to meta. How are company leaders thinking about AI expansion right now? And are you looking at any potential acquisition opportunities in a similar manner? Madison, it's great to see you and you know, this is such a, uh, accelerated time for innovation in the industry where if you think about what's happening, we are moving in AI from this kind of interactive mode of asking a question to a chatbot and intelligently getting an answer to now moving into this agentic era where agents are going to be able to autonomously, you know, complete tasks and jobs and that's going to have a very different level of, you know, appetite for infrastructure whether it be compute, power, networking, security, those are going to be pretty important, underlying kind of infrastructure components to power this movement. So we are seeing a fair amount of innovation across the board. We are pretty heavily invested in the AI industry. We're actually making sure that, you know, we've had strategic investments in multiple different companies. Uh, and uh, we just about a year ago made sure that we, um, we had a great acquisition with Splunk, which is going really well. And then there's a ton of innovation that's going on. So right now I'm tuning in from San Diego where we have 22,000 of our closest customers that we announced the largest innovation payload in the history of the company yesterday. And the reaction has been palpable because there's so much innovation that customers are starting to do to make sure that they stay relevant in this AI movement. Yeah, and G2, you have obviously been consequential in the company sort of two-year turnaround plan or reinnovation plan, I should say. And it's been interesting as someone who talks to investors a lot to hear them go from describing Cisco as a pure software name to describing it as an AI stock. What are you going to do to continue that momentum? To make sure that investors still see you as an AI play? You know, the the easy answer on that one is you have to keep innovating and staying a step ahead of the market. And uh, we are lucky in the sense that the the natural appetite with this agentic era that we're moving into is that there's going to be a demand for two things that we have in spades. The first one is, uh, you know, low latency, high performance, power efficient networking. And then the second one is safety and security so that we can make sure that we have security becoming an accelerant for adoption in this market because right now if you don't establish trust with the user, they're not going to use AI. So this is a prerequisite for AI as we move forward. So those are the two areas that we happen to be among the largest and uh, you know, we're the largest networking company in the world. We're one of the largest security companies in the world. So it happens to be that we've got the core foundation of the technology to continue to fuel this movement. And G2, I've heard you talk about how we are still just in the early innings when it comes to AI, that will move to more of an agentic AI workforce even going forward. Talk to me about how you are thinking about AI reshaping the labor market going forward here. To what degree do you see replacement of jobs? And how do you think the economy could potentially respond to that as well? You know, any such disruption and re-platforming that happens, there's going to be some jobs that change, but, uh, I don't worry as much about AI taking jobs. I worry about people that use AI better than someone else actually being the right people for the job. And so, um, there, you know, if you look at the agentic area, there's a couple things. Firstly, uh, I would I would urge people to worry less about AI taking the job but think about all the areas where we don't get to because we just simply don't have time. This agentic era is going to actually augment capacity so that we can do things that we weren't able to do because we couldn't get to it. And number two, there's going to be certain things that machines do really well, which then allow us to do things at a higher order. So I'll give you an example. Coding is one of those examples where, um, the way that coding happens today and the way that an engineer spends their time might be very different from the way they spend the time in the next three years because you'll actually see that there'll be autonomous code written, but that doesn't mean that we don't need engineers. It just means that engineers don't need to specialize a certain percentage of the time on syntax, and they can specialize on higher order bits. And and it makes me wonder too about, when we talk about your expansion plans, about the partnership with Nvidia, a move to be able to create this kind of unified architecture to simplify the build out of AI ready AI ready data center networks. To what degree does that partnership with Nvidia allow you to sort of own the networking required for AI and do you see Cisco as the leader in that move? So I'm biased and I definitely do, but if you think about the way that this market's evolving is there's an ecosystem of providers. It's ourselves, it's Nvidia, it's OpenAI, it's AMD, and we all kind of work together to make sure that we can build out these very large capacity data centers that are happening all over the world, frankly, wherever there's availability of power, you're seeing these data centers. And it would be great for having American companies be the ones that are powering and fueling these data centers. And so we happen to be one of them. We happen to have, uh, you know, at scale, one of them, one of the most credible businesses for the data centers. And I was just in the Middle East, Madison, just a couple weeks ago and we announced partnerships with, um, the humane project, which is Saudi Arabia's project for their initiative for doing data center build outs. We also announced a partnership with G42, which is the United Arab Emirates and Abu Dhabi's effort to do the same. We've announced a partnership with Stargate UAE. So you could start to expect us to be more and more present in all of these data center build outs because there's so much appetite for networking. These AI workloads are network hungry and if you actually delay the packet getting from point A to point B, that actually keeps the GPU idle and that's not a good thing. And for both training and inferencing workloads, you tend to have a fair amount of demand for high speed, low latency, high performance, energy efficient networking. G2, great overview and congratulations on the new role as well. Our first time speaking with you since that promotion. Really appreciate your time this morning. Thank you so much for having me. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
TechCrunch
a day ago
- TechCrunch
11 startups from YC Demo Day that investors are talking about
At Y Combinator's Spring 2025 Demo Day on Wednesday, nearly every presenting startup had something to do with AI — they're either developing AI agents or creating tools to facilitate their development. Indeed, several founders seem to be taking a leaf out of the pages of several successful AI startups: about half a dozen startups were presenting variations of 'Cursor for X.' For example, Den is building a 'Cursor for knowledge workers,' and Vessence is on its way to make a 'Cursor for lawyers.' It wasn't all only about AI, though. We noticed several startups are working on robotics, which seems to be having a bit of a revival at the moment. Below are some of the startups that caught both investors' and our attention. Anvil What it does: SEO for LLMs Why it's a fave: How people search for content is changing, with folks using various AI tools like ChatGPT, Gemini, Perplexity to find content. Understandably, brands need to find a way to increase their visibility on these platforms. Anvil claims it helps brands measure, optimize and increase their presence on these AI tools. Atum Works What it does: Builds 3D chips Techcrunch event Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA | REGISTER NOW Why it's a fave: Transistors aren't getting smaller as fast as they used to, so Atum's founders propose the best new way to put more transistors on a chip, and therefore increase processing power, is to stack them in three dimensions. Investors told me that Atum's vision is so revolutionary that the company has a chance to become the next NVIDIA. Auctor What it does: Automates enterprise software implementation Why it's a fave: The startup says prominent software vendors like SAP, ServiceNow, AWS and Box have already reached out to use Auctor's solution themselves and potentially for help with integrating software at customer sites. Cactus What it does: AI copilot for solopreneurs Why it's a fave: Cactus says people who run businesses all by themselves are often too busy to pursue new opportunities. The startup says its AI bot can take off some of the load by answering calls and accepting payments on your behalf. Den What it does: Cursor for enterprise knowledge workers Why it's a fave: Investors told me this is one of the hottest companies in the batch. Den promises its AI agents can replace Slack and Notion, enabling a company's employees to interact and share information with software tailored to each enterprise's specific needs. Eloquent AI What it does: Automates customer operations with AI Why it's a fave: Eloquent says its AI bots can help customers of financial services companies do things like automatically unfreeze bank accounts or add drivers to car insurance policies. In other words, Eloquent promises an end to long waits for human customer service. The startup claims financial companies can deploy its AI near instantly without needing to involve internal engineering teams. Eloquent has already raised 'a large seed round,' Tugce Bulut, the startup's co-founder and CEO said on the TBPN podcast. LLM Data Company What it does: Tooling for evaluation and reinforcement learning Why it's a fave: Evaluating all the new AI tools for quality is snowballing into a big, difficult problem. LLM Data Company says it can help with its own LLMs that can evaluate the quality of an AI agent, and it's already working with customers including Perplexity. Scalar Field What it does: AI-powered Bloomberg terminal Why it's a fave: 'Terminals are dashboards and not thinking tools,' says Amandeep Singh, co-founder of Scalar Field. While the startup's AI agents won't 'think' for you, it claims they can manipulate financial data with more flexibility than existing financial tools. Sygaldry What it does: Quantum accelerated AI servers to speed up AI training and inference Why it's a fave: While a fully functioning quantum computer may still be years away, the industry has been making progress. What caught my eye about Sygaldry is that its co-founder and CEO is Chad Rigetti, who founded and took his company public via a SPAC in 2021. Vybe What it does: Vibe coding to build applications Why it's a fave: Investors who saw a demo of Vybe building apps told me that it can create all sorts of cool tools. One person I talked to even called it a 'clear winner' of the batch.
Yahoo
3 days ago
- Yahoo
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected later this month NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. 'We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,' said Howard Jonas, Chief Executive Officer, Executive Chairman and Chairman of the Board of Rafael Holdings. Mr. Jonas added, 'We have enhanced our financial position with the closing of a $25 million rights offering earlier this month which will support advancing this potential new treatment option for patients suffering from this rare genetic disease.' Rafael Holdings, Inc. Third Quarter Fiscal Year 2025 Financial Results As of April 30, 2025, we had cash and cash equivalents of $37.9 million. On June 4, 2025, the Company announced the closing of a $25 million rights offering, which, including the funding of the backstop commitment by the Jonas family, raised net proceeds of $24.9 million after deduction of certain expenses incurred in connection with the offering. For the three months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $4.8 million, or $0.19 per share, versus a net loss of $32.4 million, or $1.36 per share in the year ago period. The year over year decrease in net loss is attributable to non-cash items, primarily unrealized losses of $1.4 million on the Company's investment in Cyclo equity which we purchased in advance of the potential merger in the current period versus $4.4 million in the year ago period, combined with an in-process R&D expense of $89.9 million related to the acquisition of Cornerstone, partially offset by a $31.3 million recovery of receivables from Cornerstone in the year ago period. Research and development expenses were $3.0 million for the three months ended April 30, 2025, compared to $1.5 million in the year ago period. The year over year increase relates to the inclusion in the current year period of spending at Cyclo Therapeutics following the March 25, 2025 merger and the activity of Cornerstone and Day Three which were consolidated with Rafael Holdings during fiscal 2024. General and administrative expenses were $3.2 million for the three months ended April 30, 2025, compared to $1.9 million in the year ago period. The year over year increase relates to the inclusion of Cyclo Therapeutics following closing of the merger, and the activity of Cornerstone and Day Three, following their consolidation. Rafael Holdings, Inc. First Nine Months Fiscal Year 2025 Financial Results For the nine months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $18.4 million, or $0.73 per share, versus a net loss of $29.9 million, or $1.26 per share in the year ago period. The year over year decrease in net loss is attributable to in-process R&D expense of $89.9 million related to the acquisition of Cornerstone net with a $31.3 million recovery of receivables from Cornerstone in the year ago period and $3.2 million in unrealized gains on the Company's investment in Cyclo equity. Research and development expenses were $5.3 million for the nine months ended April 30, 2025, compared to $2.6 million in the year ago period. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. For the nine months ended April 30, 2025, general and administrative expenses were $8.3 million compared to $6.5 million in the same period in the prior year. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. About Rafael Holdings, Inc. Rafael Holdings, Inc. holds interests in clinical and early-stage pharmaceutical and certain other companies, including our wholly owned subsidiary, Cyclo Therapeutics, LLC, a clinical stage biotechnology company dedicated to developing Rafael's lead clinical candidate, Trappsol® Cyclo™, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 ('NPC1'), a rare, fatal, and progressive genetic disorder. Rafael also holds majority equity interests in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their existing cannabis offerings. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended July 31, 2024, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact:Barbara 274-2825 RAFAEL HOLDINGS, INC. CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) April 30, 2025 July 31, 2024 (audited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 37,936 $ 2,675 Available-for-sale securities — 63,265 Interest receivable — 515 Prepaid clinical trial costs 2,968 — Convertible note receivables, due from Cyclo — 5,191 Accounts receivable, net of allowance for credit losses of $245 at April 30, 2025 and July 31, 2024 414 426 Inventory 288 — Prepaid expenses and other current assets 837 430 Total current assets 42,443 72,502 Property and equipment, net 1,614 2,120 Non-current prepaid clinical trial costs 1,399 — Investments – Cyclo — 12,010 Investments - Hedge Funds — 2,547 Convertible note receivable classified as available-for-sale 1,719 1,146 Goodwill 28,278 3,050 Intangible assets, net 1,027 1,847 In-process research and development 31,575 1,575 Other assets 41 35 TOTAL ASSETS $ 108,096 $ 96,832 LIABILITIES AND EQUITY CURRENT LIABILITIES Accounts payable $ 7,793 $ 2,556 Accrued expenses 1,866 1,798 Convertible notes payable 614 614 Other current liabilities 93 113 Due to related parties 664 733 Installment note payable — 1,700 Total current liabilities 11,030 7,514 Accrued expenses, noncurrent 3,445 2,982 Convertible notes payable, noncurrent 76 73 Other liabilities 25 5 Deferred income tax liability 9,002 — TOTAL LIABILITIES 23,578 10,574 COMMITMENTS AND CONTINGENCIES EQUITY Class A common stock, $0.01 par value; 35,000,000 shares authorized, 787,163 shares issued and outstanding as of April 30, 2025 and July 31, 2024 8 8 Class B common stock, $0.01 par value; 200,000,000 shares authorized, 31,240,188 issued and outstanding (excluding treasury shares of 101,487) as of April 30, 2025, and 24,142,535 issued and 23,819,948 outstanding (excluding treasury shares of 101,487) as of July 31, 2024 312 238 Additional paid-in capital 296,648 280,048 Accumulated deficit (220,169 ) (201,743 ) Treasury stock, at cost; 101,487 Class B shares as of October 31, 2024 and July 31, 2024 (168 ) (168 ) Accumulated other comprehensive income related to unrealized income on available-for-sale securities 219 111 Accumulated other comprehensive income related to foreign currency translation adjustment 3,728 3,691 Total equity attributable to Rafael Holdings, Inc. 80,578 82,185 Noncontrolling interests 3,940 4,073 TOTAL EQUITY 84,518 86,258 TOTAL LIABILITIES AND EQUITY $ 108,096 $ 96,832 RAFAEL HOLDINGS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited, in thousands, except share and per share data) Three Months Ended April 30, Nine Months Ended April 30, 2025 2024 2025 2024 Revenues $ 362 $ 336 $ 567 $ 472 Cost of Infusion Technology revenue 31 85 106 85 Cost of product revenue 9 — 9 — SG&A Expenses 3,170 1,923 8,284 6,524 R&D Expenses 3,003 1,526 5,276 2,627 In-process R&D expense — 89,861 — 89,861 Depreciation and amortization 62 102 238 157 Loss on impairment of goodwill — — 3,050 — Operating Loss (5,913 ) (93,161 ) (16,396 ) (98,782 ) Interest income 472 502 1,529 1,777 Loss on initial investment in Day Three upon acquisition — — — (1,633 ) Realized gain on available-for-sale securities — 945 178 1,521 Realized loss on investment in equity securities — — — (46 ) Realized gain on investment - Cyclo — — — 424 Unrealized (loss) gain on investments - Cyclo (1,393 ) (4,395 ) (5,144 ) 3,199 Unrealized gain (loss) on convertible notes receivable, due from Cyclo 383 — (719 ) — Unrealized loss on investments - Hedge Funds — (3 ) — (118 ) Recovery of receivables from Cornerstone — 31,305 — 31,305 Interest expense (165 ) (85 ) (490 ) (85 ) Other income, net 154 — 74 118 Loss before Incomes Taxes (6,462 ) (64,892 ) (20,968 ) (62,320 ) Benefit from income taxes 2,411 2,599 2,379 2,593 Equity in loss of Day Three — — — (422 ) Consolidated net loss (4,051 ) (62,293 ) (18,589 ) (60,149 ) Net income (loss) attributable to noncontrolling interests 728 (29,942 ) (163 ) (30,207 ) Net loss attributable to Rafael Holdings, Inc. $ (4,779 ) $ (32,351 ) $ (18,426 ) $ (29,942 ) Loss per share Basic and diluted (0.19 ) (1.36 ) (0.73 ) (1.26 ) Loss per basic common share $ (0.19 ) $ (1.36 ) $ (0.73 ) $ (1.26 ) Weighted average shares in calculation 25,238,501 23,777,493 23,131,655 23,687,781 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
